Observational study on the efficacy of multimodal complex therapy and Viscum album extract in the treatment of patients with advanced lung cancer

Observational study on the efficacy of multimodal complex therapy and Viscum album extract in the treatment of patients with advanced lung cancer - ACCEPT-1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022891

Enrollment

Registered

2020-08-19

Start date

2017-01-09

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Standard of care (SOC) p SOC = chemotherapy, immunoncological therapy, radiation therapy. Group 2: Standard of care (SOC) plus ACCEPT: SOC = chemotherapy, immunoncological therapy, radiati

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Expected three months participation in ACCEPT possible German language Once a week in hospital Participation in the education program

Exclusion criteria

Exclusion criteria: No German language Expected to last less than three months Mobility to weekly therapy not given

Design outcomes

Primary

Measure	Time frame
Feasibility of ACCEPT: Number of patients who can complete the program as specified and do not prematurely discontinue therapy and allow the quality of life measurement to be answered using the FACT-L questionnaire	—

Secondary

Measure	Time frame
Feasibility of randomisation Measurability of the QoL	—

Countries

Germany

Contacts

Public ContactChristian Grah

Forschungsinstitut Havelhöhe gGmbH

lunge@havelhoehe.de0049 (0)30 36501 289

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026